Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation

被引:264
作者
Feng, Chao [1 ]
Wang, Zhiguo [2 ]
Jiang, Changqing [3 ]
Kong, Ming [1 ]
Zhou, Xuan [1 ]
Li, Yang [1 ]
Cheng, Xiaojie [1 ]
Chen, Xiguang [1 ]
机构
[1] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China
[2] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266003, Peoples R China
[3] Qingdao Municipal Hosp, Qingdao 266003, Peoples R China
基金
中国国家自然科学基金;
关键词
Chitosan; Carboxymethyl chitosan; Doxorubicin hydrochloride; pH-responsive; Oral drug delivery; DOXORUBICIN; ABSORPTION;
D O I
10.1016/j.ijpharm.2013.07.079
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The present study investigated the ability of a polyelectrolyte complex (CS/CMCS-NPs), composed of chitosan (CS) and o-carboxymeymethy chitosan (CMCS) as a pH responsive carrier for oral delivery of doxorubicin hydrochloride (DOX). The obtained CS/CMCS-NPs were characterized for various parameters including morphology, particle size, zeta potential, entrapment efficiency and stability under the simulated GI tract conditions. The pH responsive stability of the DOX-loaded CS/CMCS nanoparticles (DOX: CS/CMCS-NPs) determined the drug release rate, which was lower in acidic pH than the neutral. Ex vivo intestinal adhesion and permeation indicated DOX: CS/CMCS-NGs were able to enhance absorption of DOX throughout the entire small intestine, especially in jejunum and ileum. Oral administration of DOX: CS/CMCS-NPs was effective to deliver DOX into blood, giving an absolute bioavailability of 42%. The tissue distribution and toxicity of DOX: CS/CMCS-NPs in rats showed low level of DOX in heart and kidney, and obviously decreased cardiac and renal toxicities. These results indicated CS/CMCS-NPs were highly efficient and safe as an oral delivery system for DOX. (C) 2013 Elsevier B. V. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 24 条
[1]
Selective determination of doxorubicin and doxorubicinol in rat plasma by HPLC with photosensitization reaction followed by chemiluminescence detection [J].
Ahmed, Sameh ;
Kishikawa, Naoya ;
Ohyama, Kaname ;
Wada, Mitsuhiro ;
Nakashima, Kenichiro ;
Kuroda, Naotaka .
TALANTA, 2009, 78 (01) :94-100
[2]
P-glycoproteins and multidrug resistance [J].
Bellamy, WT .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 :161-183
[3]
Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability [J].
Benival, Derajram M. ;
Devarajan, Padma V. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) :554-561
[4]
Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers [J].
Bromberg, L ;
Alakhov, V .
JOURNAL OF CONTROLLED RELEASE, 2003, 88 (01) :11-22
[5]
Chemical characteristics of O-carboxymethyl chitosans related to the preparation conditions [J].
Chen, XG ;
Park, HJ .
CARBOHYDRATE POLYMERS, 2003, 53 (04) :355-359
[6]
Role of chitosan nanoparticles in the oral absorption of Gemcitabine [J].
Derakhshandeh, Katayoun ;
Fathi, Sahar .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 437 (1-2) :172-177
[7]
Feng C., 2011, FRONT CHEM CHINA, V6, P31
[8]
pH sensitive polyelectrolyte complex of O-carboxymethyl chitosan and poly (acrylic acid) cross-linked with calcium for sustained delivery of acid susceptible drugs [J].
Gujarathi, Nayan A. ;
Rane, Bhushan R. ;
Patel, Jayvadan K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 436 (1-2) :418-425
[9]
Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan [J].
Hsu, Li-Wen ;
Lee, Pei-Ling ;
Chen, Chiung-Tong ;
Mi, Fwu-Long ;
Juang, Jyuhn-Huarng ;
Hwang, Shiaw-Min ;
Ho, Yi-Cheng ;
Sung, Hsing-Wen .
BIOMATERIALS, 2012, 33 (26) :6254-6263
[10]
Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In vivo Pharmacokinetics and Toxicity Studies in Rats [J].
Kalaria, D. R. ;
Sharma, G. ;
Beniwal, V. ;
Kumar, M. N. V. Ravi .
PHARMACEUTICAL RESEARCH, 2009, 26 (03) :492-501